Stephen Foley: Pearls of wisdom on healthcare would be welcome from the Sage of Omaha

 

US Outlook It is always a treat and an education to be in the presence of Warren Buffett. The tens of thousands who make the annual pilgrimage to the Oracle of Omaha invariably come away with a few new pearls of investment wisdom, and a witty one-liner or two, as well.

You can expect the questions to be especially pointed today, when Mr Buffett addresses the annual meeting of his company, Berkshire Hathaway, for the first time since announcing he has been diagnosed with prostate cancer.

There are a number of big questions that he should answer – and one that he must not.

The one he must not is the one about the succession. Who will be chief executive after you? Will you not push him forward, so we can get used to him and he can get used to the limelight?

The voices calling for Mr Buffett to name names are growing stronger. In February, he revealed that Berkshire Hathaway's board had picked the next chief executive from the ranks of the conglomerate's subsidiary companies – although it will remain a secret, even from the candidate himself. And then last month, there was the cancer diagnosis, another intimation of 81-year-old Mr Buffett's mortality.

Not that the cancer is especially likely to incapacitate him, or even much slow him down. Berkshire shareholders have boned up on enough oncology over the past few weeks to know that a majority of men over 80 have slow-growing prostate cancer and that it won't be what kills most of them. Mr Buffett will have to skip a few business trips while he has treatment this summer, but his prognosis is good.

So if you think there will be a brooding mood at today's shareholder meeting, I'll bet you that you're wrong. Berkshire investors are a sunny, optimistic lot, in the image of Mr Buffett himself.

As for intimations of mortality, Mr Buffett has been making jokes about his age for, oh, decades now.

For this reason, I trust that the voices calling for a name can be resisted. The transition to new leadership would actually be less smooth if the successor were named now and promoted to a dubiously useful "chief operating officer" role, say. For starters, the overlooked contenders would be disillusioned and liable to being poached. Worse, there is the risk of factions and differences of opinion between the two men. It wouldn't exactly be Blair vs Brown, but you see the risk.

While I am hoping that Mr Buffett sticks to his guns and stays mum on this one, there are other questions relating to his cancer diagnosis that I do hope he answers.

The first among these is why he opted to be tested for prostate cancer in the first place, when the medical community is split on the usefulness of such screening. The second is why he has opted for a two-month treatment of daily radiation, whose side-effects can often be more severe than anything likely to be visited upon you by a glacially growing cancer.

There are no right answers in the medical debate that Mr Buffett has brought to the fore these past few weeks, but in the US these questions touch on wealth and inequality as much as on doctors' orders. One of the reasons US health spending is on course to bankrupt the country is the prolific use of screening and medical treatments of dubious value among those rich or lucky enough to have gold-plated health insurance, with the public healthcare system forced to keep up with that supposed gold standard.

The Oracle of Omaha has used his public platform not just to dispense investment wisdom and to crack wise, but to champion charitable giving by the wealthy and to demand the rich pay a fairer amount of tax. As such, he is already morphing from business guru to political philosopher.

It is time for him to weigh in to the healthcare debate, too, with insights that will no doubt be as smart as they are personal. Like I said, always a treat, always an education.

Start your day with The Independent, sign up for daily news emails
ebooks
ebooksA special investigation by Andy McSmith
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + OTE £45,000: SThree: SThree Group have been well e...

Ashdown Group: IT Manager / Development Manager - NW London - £58k + 15% bonus

£50000 - £667000 per annum + excellent benefits : Ashdown Group: IT Manager / ...

Recruitment Genius: Sales Consultant / Telemarketer - OTE £20,000

£13000 - £20000 per annum: Recruitment Genius: Scotland's leading life insuran...

Ashdown Group: Training Programme Manager - City, London

£40000 - £45000 per annum + benefits : Ashdown Group: Training Programme Manag...

Day In a Page

Where the spooks get their coffee fix: The busiest Starbucks in the US is also the most secretive

The secret CIA Starbucks

The coffee shop is deep inside the agency's forested Virginia compound
Revealed: How the Establishment closed ranks over fallout from Loch Ness Monster 'sighting'

How the Establishment closed ranks over fallout from Nessie 'sighting'

The Natural History Museum's chief scientist was dismissed for declaring he had found the monster
One million Britons using food banks, according to Trussell Trust

One million Britons using food banks

Huge surge in number of families dependent on emergency food aid
Excavation at Italian cafe to fix rising damp unearths 2,500 years of history in 3,000 amazing objects

2,500 years of history in 3,000 amazing objects

Excavation at Italian cafe to fix rising damp unearths trove
The Hubble Space Telescope's amazing journey, 25 years on

The Hubble Space Telescope's amazing journey 25 years on

The space telescope was seen as a costly flop on its first release
Did Conservative peer Lord Ashcroft quit the House of Lords to become a non-dom?

Did Lord Ashcroft quit the House of Lords to become a non-dom?

A document seen by The Independent shows that a week after he resigned from the Lords he sold 350,000 shares in an American company - netting him $11.2m
Apple's ethnic emojis are being used to make racist comments on social media

Ethnic emojis used in racist comments

They were intended to promote harmony, but have achieved the opposite
Sir Kenneth Branagh interview: 'My bones are in the theatre'

Sir Kenneth Branagh: 'My bones are in the theatre'

The actor-turned-director’s new company will stage five plays from October – including works by Shakespeare and John Osborne
The sloth is now the face (and furry body) of three big advertising campaigns

The sloth is the face of three ad campaigns

Priya Elan discovers why slow and sleepy wins the race for brands in need of a new image
How to run a restaurant: As two newbies discovered, there's more to it than good food

How to run a restaurant

As two newbies discovered, there's more to it than good food
Record Store Day: Remembering an era when buying and selling discs were labours of love

Record Store Day: The vinyl countdown

For Lois Pryce, working in a record shop was a dream job - until the bean counters ruined it
Usher, Mary J Blige and Will.i.am to give free concert as part of the Global Poverty Project

Mary J Blige and Will.i.am to give free concert

The concert in Washington is part of the Global Citizen project, which aims to encourage young people to donate to charity
10 best tote bags

Accessorise with a stylish shopper this spring: 10 best tote bags

We find carriers with room for all your essentials (and a bit more)
Paul Scholes column: I hear Manchester City are closing on Pep Guardiola for next summer – but I'd also love to see Jürgen Klopp managing in England

Paul Scholes column

I hear Manchester City are closing on Pep Guardiola for next summer – but I'd also love to see Jürgen Klopp managing in England
Jessica Ennis-Hill: 'I just want to give it my best shot'

Jessica Ennis-Hill: 'I just want to give it my best shot'

The heptathlete has gone from the toast of the nation to being a sleep-deprived mum - but she’s ready to compete again. She just doesn't know how well she'll do...